Cite

HARVARD Citation

    Petreni, P. et al. (2015). Outcome of Crizotinib Treatment in a Young Woman with Heavily Pretreated ROS1-positive Lung Cancer. Tumori. 101 (3), pp. e103-e106. [Online]. 
  
Back to record